Stock COLUCID PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News CoLucid Pharmaceuticals Inc

Equities

US19716T1016

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for CoLucid Pharmaceuticals Inc

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CoLucid Pharmaceuticals : Lilly Completes Acquisition of CoLucid Pharmaceuticals
PR
Bragar Eagel & Squire, P.C. : Is Investigating the Board of Directors of CoLucid Pharmaceuticals, Inc. (CLCD) on Behalf of Stockholders and Encourages Investors to Contact the Firm
BU
Brower Piven Commences An Investigation Into The Proposed Sale Of CoLucid Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information
BU
Brower Piven Commences An Investigation Into The Proposed Sale Of CoLucid Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information
BU
COLUCID PHARMACEUTICALS, INC. Former SEC Attorney Willie Briscoe Believes the Acquisition by Eli Lilly and Company May be Unfair to Shareholders
BU
CoLucid Pharmaceuticals : Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid
PR
Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid
GL
CoLucid Pharmaceuticals : Research Reports Initiation on Biotech Stocks -- Arrowhead Pharma, Intra-Cellular Therapies, Synthetic Biologics, and CoLucid Pharma
PR
CoLucid Pharmaceuticals to Present at the 28th Annual Piper Jaffray Healthcare Conference
GL
CoLucid Pharmaceuticals Provides SPARTAN Enrollment Update
GL
CoLucid Pharmaceuticals Announces 2016 Third Quarter Results and Corporate Highlights
GL
CoLucid Pharmaceuticals to Present at the Stifel 2016 Healthcare Conference
GL
CoLucid Pharmaceuticals Announces Additional Analyses of Lasmiditan’s Onset of Action Data from SAMURAI and Supporting Non-Clinical Data
GL
CoLucid Pharmaceuticals to Present at the Ladenburg Thalmann 2016 Healthcare Conference
GL
CORRECTING and REPLACING – CoLucid Pharmaceuticals Provides Interim Update on GLADIATOR
GL
CoLucid Pharmaceuticals Provides Interim Update on GLADIATOR
GL
CoLucid Pharmaceuticals : Why CoLucid Pharmaceuticals Inc. Soared As Much As 18% on Thursday
PU
CoLucid Pharmaceuticals : Micro cap CoLucid spikes on positive PhIII migraine data
PU
CoLucid Pharmaceuticals : Cambridge drugmaker’s stock price finds relief after migraine drug passes major trial
PU
CoLucid Pharmaceuticals Announces Achievement of Secondary Endpoints in SAMURAI
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News CoLucid Pharmaceuticals Inc